IQVIA to Announce Second-Quarter 2022 Results on July 21, 2022
IQVIA Holdings Inc. (NYSE:IQV) has announced the upcoming release of its second-quarter 2022 financial results, scheduled for July 21, 2022, before the market opens. A conference call and webcast will follow at 9:00 a.m. Eastern Time that same day. The earnings release and detailed financial information will be available on the IQVIA Investor Relations website. A replay of the webcast will be accessible two hours after the event concludes, further enhancing investor engagement.
- None.
- None.
To listen to the event and view the presentation slides via webcast, join from the IQVIA Investor Relations website at http://ir.iqvia.com. To participate in the conference call, interested parties must register in advance by clicking on this link. Following registration, participants will receive a confirmation email containing details on how to join the conference call, including the dial-in and a unique passcode and registrant ID. At the time of the live event, registered participants can connect to the call using the information provided in the confirmation email and will be placed directly into the call.
A replay of the webcast will be available approximately two hours after the conclusion of the live event. To access the webcast recording, visit http://ir.iqvia.com.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 82,000 employees, IQVIA conducts operations in more than 100 countries.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
IQVIAFIN
View source version on businesswire.com: https://www.businesswire.com/news/home/20220707005729/en/
+1.973.316.3828
+1.484.567.6732
Source:
FAQ
When will IQVIA release its Q2 2022 financial results?
What time is the IQVIA Q2 2022 earnings call?
Where can I find IQVIA's financial results?
How can I participate in the IQVIA earnings call?